These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35468997)

  • 1. Flat intraurothelial lesions of the urinary bladder-do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice.
    Paner GP; Smith SC; Hartmann A; Agarwal PK; Compérat E; Amin MB
    Mod Pathol; 2022 Oct; 35(10):1296-1305. PubMed ID: 35468997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urothelial dysplasia of the bladder: diagnostic features and clinical significance.
    Lopez-Beltran A; Montironi R; Vidal A; Scarpelli M; Cheng L
    Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):121-9. PubMed ID: 24344498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features.
    Hodges KB; Lopez-Beltran A; Davidson DD; Montironi R; Cheng L
    Hum Pathol; 2010 Feb; 41(2):155-62. PubMed ID: 19762067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysplasia and carcinoma in situ of the urinary bladder.
    Lopez-Beltran A; Marques RC; Montironi R; Reymundo C; Fonseca J; Cheng L
    Anal Quant Cytopathol Histpathol; 2015 Feb; 37(1):29-38. PubMed ID: 26072632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Next-Generation Sequencing of Flat Urothelial Lesions Reveals Putative Pathobiological Pathways, Potential Biomarkers, and Rational Therapeutic Targets.
    Musangile FY; Matsuzaki I; Iwamoto R; Sagan K; Nishikawa M; Mikasa Y; Takahashi Y; Kojima F; Hara I; Murata SI
    Mod Pathol; 2023 May; 36(5):100120. PubMed ID: 36812689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions].
    Sibony M; Billerey C
    Ann Pathol; 2003 Feb; 23(1):35-45. PubMed ID: 12743498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flat intraepithelial lesions of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Bostwick DG
    Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urothelial carcinoma in situ: diagnostic update.
    McKenney JK
    Pathology; 2021 Jan; 53(1):86-95. PubMed ID: 33234229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of atypical papillary urothelial hyperplasia.
    Swierczynski SL; Epstein JI
    Hum Pathol; 2002 May; 33(5):512-7. PubMed ID: 12094376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preneoplastic lesions and precursors of urothelial cancer].
    Knüchel-Clarke R; Gaisa NT
    Pathologe; 2016 Feb; 37(1):33-9. PubMed ID: 26811248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lewis(y) antigen (blood group 8, BG8) is a useful marker in the histopathological differential diagnosis of flat urothelial lesions of the urinary bladder.
    Gunia S; Kakies C; May M; Koch S; Erbersdobler A
    J Clin Pathol; 2011 Aug; 64(8):672-6. PubMed ID: 21512109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Revisions in the WHO histological classification of urothelial bladder tumors and flat urothelial lesions].
    Helpap B; Köllermann J
    Pathologe; 2000 May; 21(3):211-7. PubMed ID: 10900613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation.
    Lopez-Beltran A; Cheng L; Andersson L; Brausi M; de Matteis A; Montironi R; Sesterhenn I; van det Kwast KT; Mazerolles C
    Virchows Arch; 2002 Jan; 440(1):3-11. PubMed ID: 11942574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraepithelial lesions of urinary bladder: morphologic considerations.
    Murphy WM; Busch C; Algaba F
    Scand J Urol Nephrol Suppl; 2000; (205):67-81. PubMed ID: 11144906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advances in diagnosis of flat lesions of urinary bladder].
    Cheng L; Xu JW; Teng XD
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):577-81. PubMed ID: 21092582
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudocarcinomatous urothelial hyperplasia of the bladder: clinical findings and followup of 70 patients.
    Kryvenko ON; Epstein JI
    J Urol; 2013 Jun; 189(6):2083-6. PubMed ID: 23228381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precursor lesions of the urinary bladder.
    McKenney JK
    Histopathology; 2019 Jan; 74(1):68-76. PubMed ID: 30565304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion.
    McKenney JK; Gomez JA; Desai S; Lee MW; Amin MB
    Am J Surg Pathol; 2001 Mar; 25(3):356-62. PubMed ID: 11224606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and immunohistologic analyses cannot reliably solve diagnostic variation of flat intraepithelial lesions of the urinary bladder.
    Murata S; Iseki M; Kinjo M; Matsuzaki O; Moriuchi A; Ohtani H; Sakurai T; Satake T; Tsuzuki T
    Am J Clin Pathol; 2010 Dec; 134(6):862-72. PubMed ID: 21088148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.